CN Patent

CN114306218B — 满足药学抑菌要求的经粘膜给药r-氯胺酮药物组合物

Assigned to Sichuan Pu Et Pharmaceutical Co ltd · Expires 2023-11-10 · 3y expired

What this patent protects

本发明提供一种经粘膜给药特别是经鼻给药的R‑氯胺酮药物组合物，其为含有防腐剂的水性药物制剂，具有良好的药学稳定性以及所期望的抑菌效力。

USPTO Abstract

本发明提供一种经粘膜给药特别是经鼻给药的R‑氯胺酮药物组合物，其为含有防腐剂的水性药物制剂，具有良好的药学稳定性以及所期望的抑菌效力。

Drugs covered by this patent

esketamine-hydrochloride (ESKETAMINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN114306218B
Jurisdiction: CN
Classification: —
Expires: 2023-11-10
Drug substance claim: No
Drug product claim: No
Assignee: Sichuan Pu Et Pharmaceutical Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.